| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/01/2005 | EP1534241A1 Transdermal aerosol compositions |
| 06/01/2005 | EP1534239A2 Preparation of submicron sized particles with polymorph control and new polymorph of itraconazole |
| 06/01/2005 | EP1534238A1 Formulations and dosage forms for controlled delivery of topiramate |
| 06/01/2005 | EP1534236A1 Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders |
| 06/01/2005 | EP1534234A1 Composition and use thereof as a pharmaceutical or cosmetic formulation for external application |
| 06/01/2005 | EP1534232A1 Repair of dna mutagenic damage |
| 06/01/2005 | EP1534231A2 Method and compositions for inducing production of fibrous organic tissue |
| 06/01/2005 | EP1534074A2 Combination therapy for the treatment of obesity |
| 06/01/2005 | EP1534072A2 Anthelmintic oral homogeneous veterinary pastes |
| 06/01/2005 | EP1534070A2 Methods for treating fungal infections |
| 06/01/2005 | EP1499278B1 Immediate-release pharmaceutical dosage form comprising polymorphous tibolone |
| 06/01/2005 | EP1453820B1 Substituted 6h-dibenzo[c,h]chromenes as estrogenic agents |
| 06/01/2005 | EP1416936B1 Thiopyrane-4-ones as dna protein kinase inhibitors |
| 06/01/2005 | EP1411926B1 Integrin inhibitors for the treatment of eye diseases |
| 06/01/2005 | EP1404330B1 Substituted 8-arylquinoline pde4 inhibitors |
| 06/01/2005 | EP1395231B1 Preparation for the removal of abnormal keratin material |
| 06/01/2005 | EP1385847B1 Pyrazolo[1,5-a]pyridine derivatives |
| 06/01/2005 | EP1383539A4 Anticancer drug-chitosan complex forming self-aggregates and preparation method thereof |
| 06/01/2005 | EP1351959B1 Novel pleuromutilin derivatives |
| 06/01/2005 | EP1347760B1 Nmda receptor agonist pharmaceutical compositions |
| 06/01/2005 | EP1345902B1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same |
| 06/01/2005 | EP1335730B1 Use of pde5 inhibitors for the treatment of premature ejaculation |
| 06/01/2005 | EP1280526B1 Use of 2-iminobiotin for the manufacture of a medicament for the prevention and/or treatment, in newborn babies, of the effects of complications during childbirth |
| 06/01/2005 | EP1268465B1 Triarylimidazole derivatives as cytokine inhibitors |
| 06/01/2005 | EP1265614B1 Novel galenical form for oral administration with prolonged release of molsidomine |
| 06/01/2005 | EP1254136A4 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF |
| 06/01/2005 | EP1248761A4 Compounds which mimic the chemical and biological properties of discodermolide |
| 06/01/2005 | EP1233951B1 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors |
| 06/01/2005 | EP1228030B1 Benzenoid derivatives of 15-hydroxyeicosatetraenoic acid and methods of their use in treating dry eye disorders |
| 06/01/2005 | EP1188754B1 Substituted pyrazole compounds |
| 06/01/2005 | EP1178977B1 Ion channel modulating agents |
| 06/01/2005 | EP1173205B1 An oral formulation for ileum administering comprising an inhibitor compound of the ileal bile acid transport |
| 06/01/2005 | EP1148871B1 Core tablet for controlled release of gliclazide after oral administration |
| 06/01/2005 | EP1143927B1 Facial tissue composition and method of use for sequestration of nasal secretion skin irritants |
| 06/01/2005 | EP1131061B1 Agent for lowering prolactin |
| 06/01/2005 | EP1119321B1 Patient temperature regulation method and apparatus |
| 06/01/2005 | EP1115695B1 (r)-chiral halogenated 1-substitutedamino-(n+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity |
| 06/01/2005 | EP1100878B1 Process for producing genetically modified cd34-negative adherently growing haematopoietic stem cells |
| 06/01/2005 | EP1095015B1 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
| 06/01/2005 | EP1062210B1 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors |
| 06/01/2005 | EP1058553B1 Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytopathy |
| 06/01/2005 | EP1049679B1 Sulphonamide derivatives for treatment of cns disorders |
| 06/01/2005 | EP1003744B1 4-AMINOPYRROLE(3,2-d) PYRIMIDINES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS |
| 06/01/2005 | EP0994862B1 Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation |
| 06/01/2005 | EP0991625B1 Inhibitors of factor xa with a neutral p1 specificity group |
| 06/01/2005 | EP0981353B1 Facilitation of repair of neural injury with cm101/gbs toxin |
| 06/01/2005 | EP0954573B1 Preparation of ionically cross-linked polyphosphazene microspheres by coacervation |
| 06/01/2005 | EP0946499B1 N-(aryl/heteroaryl/alkylacetyl) amino acid amides, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 06/01/2005 | EP0944310B8 Stabilized ascorbyl compositions |
| 06/01/2005 | EP0929563B1 6-o-substituted ketolides having antibacterial activity |
| 06/01/2005 | EP0909327B1 Erythromycins and process for their preparation |
| 06/01/2005 | EP0906433B1 Protein tyrosine phosphatases of hematopoietic cells |
| 06/01/2005 | EP0873110B1 Improved hemostatic composition for treating gingival area |
| 06/01/2005 | EP0794963B1 Xanthine derivatives compounds useful for activating chloride conductance in animal cells |
| 06/01/2005 | EP0751761B1 Active substances and compositions for the therapy of senile xerosis |
| 06/01/2005 | CN1623001A System for monitoring bacterial tumor treatment |
| 06/01/2005 | CN1622994A TGF-beta-specific covalently closed antisense molecule |
| 06/01/2005 | CN1622956A Cytotoxic cyplasin of the sea hare, aplysia punctata, cdna cloning and expression of bioreactive recombinants |
| 06/01/2005 | CN1622946A Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors |
| 06/01/2005 | CN1622945A Thiazolidinedione derivatives and pharmaceutical composition comprising the same |
| 06/01/2005 | CN1622942A HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 06/01/2005 | CN1622941A Glutaminyl based DPIV inhibitors |
| 06/01/2005 | CN1622939A 9-aminoacridine derivatives and process for the preparation thereof |
| 06/01/2005 | CN1622938A 方法 Method |
| 06/01/2005 | CN1622937A Process for the manufacture of HMG-coa reductase inhibitors |
| 06/01/2005 | CN1622936A Process for the preparation of high purity perindopril and intermediates useful in the synthesis |
| 06/01/2005 | CN1622934A Short-acting sedative hypnotic agents for anesthesia and sedation |
| 06/01/2005 | CN1622820A Therapeutic cream for dermatitis |
| 06/01/2005 | CN1622819A An anti-rheumatism medicament and preparation method thereof |
| 06/01/2005 | CN1622818A Therapeutic lotion for dermatitis |
| 06/01/2005 | CN1622816A Composition and method for augmenting kidney function |
| 06/01/2005 | CN1622814A Use of antitumor indolopyrrolocarbazole derivative and other anticancer agent in combination |
| 06/01/2005 | CN1622813A Drug I draparinux for treating and secondary prophylaxis of vein thrombo embolism of deep vien thrombus patient |
| 06/01/2005 | CN1622812A Prophylactic and therapeutic treatment of infectious and other diseases with immune effect compound |
| 06/01/2005 | CN1622811A Use of alkylphosphocholines for the preventative treatment of protozoan diseases |
| 06/01/2005 | CN1622810A 孕酮口服药物传输系统 Progesterone oral drug delivery system |
| 06/01/2005 | CN1622809A Orodispersible pharmaceutical composition comprising ivabradine |
| 06/01/2005 | CN1622808A Treatment of gastrointestinal stromal tumors |
| 06/01/2005 | CN1622807A Phenylpyrimidine amines as IgE inhibitors |
| 06/01/2005 | CN1622806A Method for the treatment of overactive bladder |
| 06/01/2005 | CN1622805A Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative |
| 06/01/2005 | CN1622804A Orodispersible pharmaceutical composition of agomelatine |
| 06/01/2005 | CN1622803A Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontinence |
| 06/01/2005 | CN1622802A Composition for inhalation |
| 06/01/2005 | CN1622754A Novel immune effect compound |
| 06/01/2005 | CN1621411A Recombinant targeted fusion protein for treating acquired immunodeficiency syndrome |
| 06/01/2005 | CN1621404A Drug and method for regulating cholesterol and triglyceride |
| 06/01/2005 | CN1621104A Meridian point therapeutic plaster of high polymer multi hole energy gathering ion and its preparation method and application |
| 06/01/2005 | CN1621094A Gene transfer for regulating smooth muscle tone |
| 06/01/2005 | CN1621092A Folic acid receptor targeted liposome medicine carrier, its preparation and application |
| 06/01/2005 | CN1621082A Chinese traditional medicinal composition for treating acne |
| 06/01/2005 | CN1621044A Composition for preventing and treating arthritis, formulation containing said composition, its preparation process and usage |
| 06/01/2005 | CN1621043A Powder injection preparation of diammonium glycyrrhizinate and its preparation |
| 06/01/2005 | CN1621042A Freeze dried powder injection of cytarabine and its preparation process |
| 06/01/2005 | CN1621041A Pharmaceutical composition with pain easing function |
| 06/01/2005 | CN1621040A Antemetic Granisetron Hydrochloride tablet and its preparation |
| 06/01/2005 | CN1621039A Targeted preparation via nose to brain of Huperzine and its derivant or its salt |
| 06/01/2005 | CN1621038A Usage of glanthidine, total alkali extract and preparation method and usage thereof |
| 06/01/2005 | CN1621037A Application of Schisandrin-B in preparing medicine for treating tumor |
| 06/01/2005 | CN1621036A Powder injection of hydrochloric acid ranitidine and its preparation method |